ID   MILR1_HUMAN             Reviewed;         343 AA.
AC   Q7Z6M3; A1L458; B4DUS1; B7ZM50; B9EGN0; D6RUW6; D6RUW8;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   28-JUN-2023, entry version 132.
DE   RecName: Full=Allergin-1;
DE   AltName: Full=Allergy inhibitory receptor 1;
DE   AltName: Full=Mast cell antigen 32;
DE            Short=MCA-32;
DE   AltName: Full=Mast cell immunoglobulin-like receptor 1;
DE   Flags: Precursor;
GN   Name=MILR1; Synonyms=C17orf60, MCA32;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=20526344; DOI=10.1038/ni.1886;
RA   Hitomi K., Tahara-Hanaoka S., Someya S., Fujiki A., Tada H., Sugiyama T.,
RA   Shibayama S., Shibuya K., Shibuya A.;
RT   "An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-
RT   mediated immediate hypersensitivity reactions.";
RL   Nat. Immunol. 11:601-607(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Prostate, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Immunoglobulin-like receptor which plays an inhibitory role
CC       in degranulation of mast cells. Negatively regulates IgE-mediated mast
CC       cell activation and suppresses the type I immediate hypersensitivity
CC       reaction (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Interacts (tyrosine-phosphorylated) with PTPN6,
CC       PTPN11 and INPP5D. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q7Z6M3; Q6UX41-6: BTNL8; NbExp=3; IntAct=EBI-18391669, EBI-17442596;
CC       Q7Z6M3; Q8WVX3-2: C4orf3; NbExp=3; IntAct=EBI-18391669, EBI-12003442;
CC       Q7Z6M3; Q96F15: GIMAP5; NbExp=3; IntAct=EBI-18391669, EBI-6166686;
CC       Q7Z6M3; Q9HCP6: HHATL; NbExp=3; IntAct=EBI-18391669, EBI-5916693;
CC       Q7Z6M3; O75425: MOSPD3; NbExp=3; IntAct=EBI-18391669, EBI-12179105;
CC       Q7Z6M3; Q9NV12: TMEM140; NbExp=3; IntAct=EBI-18391669, EBI-2844246;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20526344};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:20526344}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=L;
CC         IsoId=Q7Z6M3-1; Sequence=Displayed;
CC       Name=2; Synonyms=S1;
CC         IsoId=Q7Z6M3-2; Sequence=VSP_040766;
CC       Name=3; Synonyms=S2;
CC         IsoId=Q7Z6M3-3; Sequence=VSP_040765;
CC   -!- TISSUE SPECIFICITY: Expressed in myeloid cells (dendritic cells,
CC       macrophages and neutrophils, weak expression on B-cells but not in T-
CC       cells or natural killer cells), peripheral blood basophils and mast
CC       cells (at protein level). {ECO:0000269|PubMed:20526344}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:20526344}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI36595.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG62433.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB542950; BAJ08251.1; -; mRNA.
DR   EMBL; AB542951; BAJ08252.1; -; mRNA.
DR   EMBL; AB542952; BAJ08253.1; -; mRNA.
DR   EMBL; AK300768; BAG62433.1; ALT_INIT; mRNA.
DR   EMBL; BC053534; AAH53534.1; -; mRNA.
DR   EMBL; BC130406; AAI30407.2; -; mRNA.
DR   EMBL; BC136594; AAI36595.1; ALT_INIT; mRNA.
DR   EMBL; BC144272; AAI44273.1; -; mRNA.
DR   CCDS; CCDS74133.1; -. [Q7Z6M3-1]
DR   CCDS; CCDS77087.1; -. [Q7Z6M3-2]
DR   CCDS; CCDS77088.1; -. [Q7Z6M3-3]
DR   RefSeq; NP_001078892.1; NM_001085423.1. [Q7Z6M3-1]
DR   RefSeq; NP_001278245.1; NM_001291316.1. [Q7Z6M3-2]
DR   RefSeq; NP_001278246.1; NM_001291317.1. [Q7Z6M3-3]
DR   RefSeq; XP_016879975.1; XM_017024486.1.
DR   AlphaFoldDB; Q7Z6M3; -.
DR   BioGRID; 129734; 76.
DR   IntAct; Q7Z6M3; 13.
DR   STRING; 9606.ENSP00000482801; -.
DR   GlyCosmos; Q7Z6M3; 6 sites, No reported glycans.
DR   GlyGen; Q7Z6M3; 6 sites.
DR   iPTMnet; Q7Z6M3; -.
DR   PhosphoSitePlus; Q7Z6M3; -.
DR   BioMuta; MILR1; -.
DR   DMDM; 160013631; -.
DR   EPD; Q7Z6M3; -.
DR   MassIVE; Q7Z6M3; -.
DR   MaxQB; Q7Z6M3; -.
DR   PeptideAtlas; Q7Z6M3; -.
DR   ProteomicsDB; 69447; -. [Q7Z6M3-1]
DR   ProteomicsDB; 69448; -. [Q7Z6M3-2]
DR   ProteomicsDB; 69449; -. [Q7Z6M3-3]
DR   Antibodypedia; 68852; 122 antibodies from 14 providers.
DR   DNASU; 284021; -.
DR   Ensembl; ENST00000612535.4; ENSP00000477504.1; ENSG00000271605.6. [Q7Z6M3-3]
DR   Ensembl; ENST00000615220.4; ENSP00000480749.1; ENSG00000271605.6. [Q7Z6M3-1]
DR   Ensembl; ENST00000616498.4; ENSP00000481318.1; ENSG00000271605.6. [Q7Z6M3-2]
DR   Ensembl; ENST00000619286.5; ENSP00000482801.1; ENSG00000271605.6. [Q7Z6M3-1]
DR   GeneID; 284021; -.
DR   KEGG; hsa:284021; -.
DR   MANE-Select; ENST00000619286.5; ENSP00000482801.1; NM_001085423.2; NP_001078892.1.
DR   UCSC; uc010wpz.4; human. [Q7Z6M3-1]
DR   AGR; HGNC:27570; -.
DR   CTD; 284021; -.
DR   DisGeNET; 284021; -.
DR   GeneCards; MILR1; -.
DR   HGNC; HGNC:27570; MILR1.
DR   HPA; ENSG00000271605; Tissue enhanced (lymphoid).
DR   MalaCards; MILR1; -.
DR   neXtProt; NX_Q7Z6M3; -.
DR   OpenTargets; ENSG00000271605; -.
DR   PharmGKB; PA142672243; -.
DR   VEuPathDB; HostDB:ENSG00000271605; -.
DR   eggNOG; ENOG502S5BW; Eukaryota.
DR   GeneTree; ENSGT01050000244808; -.
DR   HOGENOM; CLU_069833_0_0_1; -.
DR   InParanoid; Q7Z6M3; -.
DR   OMA; PVKMQKK; -.
DR   OrthoDB; 5263500at2759; -.
DR   PhylomeDB; Q7Z6M3; -.
DR   PathwayCommons; Q7Z6M3; -.
DR   SignaLink; Q7Z6M3; -.
DR   BioGRID-ORCS; 284021; 6 hits in 276 CRISPR screens.
DR   ChiTaRS; MILR1; human.
DR   GenomeRNAi; 284021; -.
DR   Pharos; Q7Z6M3; Tbio.
DR   PRO; PR:Q7Z6M3; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q7Z6M3; protein.
DR   Bgee; ENSG00000271605; Expressed in monocyte and 121 other tissues.
DR   ExpressionAtlas; Q7Z6M3; baseline and differential.
DR   Genevisible; Q7Z6M3; HS.
DR   GO; GO:0005886; C:plasma membrane; NAS:UniProtKB.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0043303; P:mast cell degranulation; ISS:UniProtKB.
DR   GO; GO:0033004; P:negative regulation of mast cell activation; ISS:UniProtKB.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR040878; IL-40-like_Ig.
DR   PANTHER; PTHR11481:SF58; ALLERGIN-1; 1.
DR   PANTHER; PTHR11481; IMMUNOGLOBULIN FC RECEPTOR; 1.
DR   Pfam; PF17736; Ig_C17orf99; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..343
FT                   /note="Allergin-1"
FT                   /id="PRO_0000307364"
FT   TOPO_DOM        20..227
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        228..248
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        249..343
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          35..118
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          128..213
FT                   /note="Ig-like C2-type 2"
FT   MOTIF           311..316
FT                   /note="ITIM motif"
FT   MOTIF           336..341
FT                   /note="ITIM motif"
FT   MOD_RES         313
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TB92"
FT   MOD_RES         338
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TB92"
FT   CARBOHYD        51
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        157
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        56..103
FT                   /evidence="ECO:0000250"
FT   DISULFID        147..196
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         33..122
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:20526344"
FT                   /id="VSP_040765"
FT   VAR_SEQ         123..217
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:20526344"
FT                   /id="VSP_040766"
SQ   SEQUENCE   343 AA;  38735 MW;  DCD1E784D40885C5 CRC64;
     MWSHLNRLLF WSIFSSVTCR KAVLDCEAMK TNEFPSPCLD SKTKVVMKGQ NVSMFCSHKN
     KSLQITYSLF RRKTHLGTQD GKGEPAIFNL SITEAHESGP YKCKAQVTSC SKYSRDFSFT
     IVDPVTSPVL NIMVIQTETD RHITLHCLSV NGSLPINYTF FENHVAISPA ISKYDREPAE
     FNLTKKNPGE EEEYRCEAKN RLPNYATYSH PVTMPSTGGD SCPFCLKLLL PGLLLLLVVI
     ILILAFWVLP KYKTRKAMRN NVPRDRGDTA MEVGIYANIL EKQAKEESVP EVGSRPCVST
     AQDEAKHSQE LQYATPVFQE VAPREQEACD SYKSGYVYSE LNF
//
